|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||1,851.24 - 1,929.41|
|52-week range||1,839.30 - 3,300.00|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||141.65|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
For instance, here's one thing you can bet on: Investing in companies at the forefront of growing industries that possess a competitive edge will pay rich dividends down the road. Let's look at two companies that fit this description down to a T: Abbott Laboratories (NYSE: ABT) and Adyen N.V. (OTC: ADYE.Y). Abbott Laboratories is best known as a medical devices specialist -- and it is one of the most established leaders in this field.
Adyen, the global payments platform of choice for many of the world's leading companies, today announced the launch of mobile Android point of sale (POS) terminals in the EU, UK, and the United States. The devices represent a fundamental change in the role of the payment terminal, functioning as an all-in-one solution, eliminating the need for separate cash registers, barcode scanners, and customer facing displays. Additionally, the terminals come with an app management system, allowing merchant
Adyen (AMS: ADYEN), the global payments platform of choice for many of the world's leading companies, and Cypress Five Star, Inc., a leading franchise operator, are teaming up to bring unified payments across their 60 Five Guys locations in Canada. Adyen will support in-restaurant POS payments services, creating a seamless experience for the customer while enhancing tipping functionality to benefit restaurant workers.